Pasireotide

Red

Brand Name(s):Signifor

Indication:Cushing’s disease
Acromegaly

Rationale:1,2

Considered:Mar-12

Review Date:Oct-25

Comments:
Ultrasonic examination of gallbladder before and at 6 to 12-month intervals during therapy is recommended as cholangitis reported. Cases of ketoacidosis in patients with and without history of diabetes have also been reported whilst using the drug.